Found 157 matching trials
To Develop a High Quality Health Care Delivery Model for the Management of Hypertension and Diabetes at CHCs and District Hospitals of Himachal Pradesh. NA Hypertension and diabetes are major risk factors for cardiovascular disease...
Show More Location
CHCs and District Hospital of Solan District
Learn More & Join Trial
Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate PHASE3 This is a study of two treatment pathways \[Standard steroid treatment vers...
Show More Location
University Hospital Bristol NHS Foundation Trust
Learn More & Join Trial
Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis NA The aim is to evaluate EUS-FNA efficacy for AIP diagnosis using a 22-gauge ...
Show More Location
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Diabetes Data-Assisted Remission Trial (DDART) NA The study team will study the efficacy of a high intensity medical weight l...
Show More Location
Wake Forest Univesity Health Sciences
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
The Impact of Implementing a Nursing-driven Clinical Pathway for Inpatient Management of Children With Asthma NA Asthma is the most common chronic disease of childhood and is responsible f...
Show More Location
Children's Hospital of Eastern Ontario
Learn More & Join Trial
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer PHASE2 This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Integrating Depression Care in Acute Coronary Syndromes Care in China NA The overall goal of this study is to develop, pilot test, implement, and ev...
Show More Location
The George Institute for Global Health, China
Learn More & Join Trial
Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology N/A Cirrhotic cardiomyopathy is associated with increased risk of complications...
Show More Location
Dr. Madhumita Premkumar
Learn More & Join Trial
Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT) NA The goal of the study is to evaluate a new Autism Spectrum Disorder (ASD) d...
Show More Location
Oxford Health NHS Foundation Trust
Learn More & Join Trial